OncoTracker licenses key patents from IMBCR

15:40 EDT 18 Mar 2019 | Elsevier Business Intelligence

OncoTracker Inc. penned an agreement with the Institute for Myeloma & Bone Cancer Research (IMBCR) for rights to patent famil...

Original Article: OncoTracker licenses key patents from IMBCR

More From BioPortfolio on "OncoTracker licenses key patents from IMBCR"